System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk

Tumor Biology

Volumn 33, Issue 2, 2012, Pages 523-535

  Zhao, Zhi Qiang ^a   Guan, Qing Kai ^a   Yang, Fei Yun ^a   Zhao, Peng ^a   Zhou, Bing ^a   Chen, Zhi Jun ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b The First Affiliated Hospital of Xinxiang Medical University   (China)

Author keywords

Colorectal adenoma; EPHX1; Gene polymorphism; GSTM1; GSTP1; GSTT1; Metaanalysis; NQO1

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); EPHX1 PROTEIN, HUMAN; EPOXIDE HYDROLASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GSTP1 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN;

ALLELE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; COLORECTAL ADENOMA; EPOXIDEHYDROXYLASE 1 GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GLUTATHIONE TRANSFERASE M1 GENE; GLUTATHIONE TRANSFERASE P1 GENE; GLUTATHIONE TRANSFERASE T1 GENE; HETEROZYGOTE; HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) GENE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TUMOR GENE; ADENOMA; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; META ANALYSIS; RISK;

ADENOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EPOXIDE HYDROLASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84860294407     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0287-x     Document Type: Review

References (49)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol. 2010;40:281-5.
3. Nothlings U, Yamamoto JF, Wilkens LR, Murphy SP, Park SY, Henderson BE, et al. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2009;18:2098-106.
4. Northwood EL, Elliott F, Forman D, Barrett JH, Wilkie MJ, Carey FA, et al. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Pharmacogenet Genomics. 2010;20:315-26.
5. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617-31.
6. Randi G, Edefonti V, Ferraroni M, La Vecchia C, Decarli A. Dietary patterns and the risk of colorectal cancer and adenomas. Nutr Rev. 2010;68:389-408.
7. Onega T, Goodrich M, Dietrich A, Butterly L. The influence of smoking, gender, and family history on colorectal adenomas. J Cancer Epidemiol. 2010;2010:509347.
8. Skjelbred CF, Saebo M, Hjartaker A, Grotmol T, Hansteen IL, Tveit KM, et al. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer. 2007;7:228.
9. Huang WY, Chatterjee N, Chanock S, Dean M, Yeager M, Schoen RE, et al. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14:152-7.
10. Inoue H, Kiyohara C, Marugame T, Shinomiya S, Tsuji E, Handa K, et al. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res. 2000;60:3749-52.
11. Roberts-Thomson IC, Butler WJ, Ryan P. Meat, metabolic genotypes and risk for colorectal cancer. Eur J Cancer Prev. 1999;8:207-11.
12. Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, et al. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis. 2007;28:875-82.
13. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev. 2001;10:875-82.
14. Inoue H, Kiyohara C, Shinomiya S, Marugame T, Tsuji E, Handa K, et al. Glutathione S-transferase polymorphisms and risk of colorectal adenomas. Cancer Lett. 2001;163:201-6.
15. Zhuang W, Wu XT, Zhou Y, Liu L, Liu GJ, Wu TX, et al. Interleukin10-592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci. 2010;55:1525-32.
16. Luchtenborg M, Weijenberg MP, Kampman E, van Muijen GN, Roemen GM, Zeegers MP, et al. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol. 2005;161:806-15.
17. Barker HJ, Alpert LC, Compton CC, Maslen A, Kirby GM. Loss of glutathione S-transferase (GST) mu phenotype in colorectal adenocarcinomas from patients with a GSTM1 positive genotype. Cancer Lett. 2002;177:65-74.
18. Tiemersma EW, Kloosterman J, Bunschoten A, Kok FJ, Kampman E. Role of EPHX genotype in the associations of smoking and diet with colorectal adenomas. IARC Sci Publ. 2002;156:491-3.
19. Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, et al. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 1998;7:647-52.
20. Lin HJ, Zhou H, Dai A, Huang HF, Lin JH, Frankl HD, et al. Glutathione transferase GSTT1, broccoli, and prevalence of colorectal adenomas. Pharmacogenetics. 2002;12:175-9.
21. Lin HJ, Probst-Hensch NM, Ingles SA, Han CY, Lin BK, Lee DB, et al. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res. 1995;55:1224-6.
22. Tiemersma EW, Bunschoten A, Kok FJ, Glatt H, de Boer SY, Kampman E. Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int J Cancer. 2004;108:97-103.
23. Tijhuis MJ, Visker MH, Aarts JM, Laan W, de Boer SY, Kok FJ, et al. NQO1 and NFE2L2 polymorphisms, fruit and vegetable intake and smoking and the risk of colorectal adenomas in an endoscopybased population. Int J Cancer. 2008;122:1842-8.
24. Tijhuis MJ, Wark PA, Aarts JM, Visker MH, Nagengast FM, Kok FJ, et al. GSTP1 and GSTA1 polymorphisms interact with cruciferous vegetable intake in colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2005;14:2943-51.
25. Moore LE, Huang WY, Chatterjee N, Gunter M, Chanock S, Yeager M, et al. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14:1823-7.
26. Hou L, Chatterjee N, Huang WY, Baccarelli A, Yadavalli S, Yeager M, et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis. 2005;26:1122-8.
27. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hankinson SE, Hunter DJ. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis. 2004;25:1211-8.
28. Cortessis V, Siegmund K, Chen Q, Zhou N, Diep A, Frankl H, et al. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res. 2001;61:2381-5.
29. Liu L, Zeng F, Wang K, Huang J, Xin L, Zhu PQ. Meta-analysis of the association between VEGF-634 G > C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol. 2011;137:1027-36.
30. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297-303.
31. Liu L, Zhuang W, Wang RQ, Mukherjee R, Xiao SM, Chen Z, et al. Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies. Eur J Nutr. 2011;50:173-84.
32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
33. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
34. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
35. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
36. Omiecinski CJ, Hassett C, Hosagrahara V. Epoxide hydrolase- polymorphism and role in toxicology. Toxicol Lett. 2000;112- 113:365-70.
37. Li X, Hu Z, Qu X, Zhu J, Li L, Ring BZ, et al. Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis. PLoS One. 2011;6: e14749.
38. Sims P, Grover PL, Swaisland A, Pal K, Hewer A. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature. 1974;252:326-8.
39. Brown B, Avalos J, Lee C, Doolittle D. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanol (NNAL). Mutat Res. 2001;494:21-9.
40. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994;3:421-8.
41. Hosagrahara VP, Rettie AE, Hassett C, Omiecinski CJ. Functional analysis of human microsomal epoxide hydrolase genetic variants. Chem Biol Interact. 2004;150:149-59.
42. Hassett C, Lin J, Carty CL, Laurenzana EM, Omiecinski CJ. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys. 1997;337:275-83.
43. Yang X, Liang SH, Weyant DM, Lazarus P, Gallagher CJ, Omiecinski CJ. The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. J Pharmacol Exp Ther. 2009;330:23-30.
44. Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer. 2002;37:241-56.
45. Lampe JW. Interindividual differences in response to plant-based diets: implications for cancer risk.AmJ Clin Nutr. 2009;89:1553S-7.
46. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD (P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact. 2000;129:77-97.
47. Joseph P, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA. 1994;91:8413-7.
48. Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM. Presence of a heterozygous substitution and its relationship to DTdiaphorase activity. Br J Cancer. 1995;72:555-61.
49. Xue H, Ni P, Lin B, Xu H, Huang G. X-ray repair crosscomplementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and meta-analysis. Am J Epidemiol. 2011;173:363-75.